Allied Market Research

North American Internal Neuromodulation Market - Opportunities and Forecasts, 2016 - 2022

The report offers a detailed analysis of key driving and hindering factors of the North American internal neuromodulation market.

 

Portland, OR -- (SBWIRE) -- 07/27/2017 -- Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.

Get full summary of the Report: https://www.alliedmarketresearch.com/north-america-internal-neuromodulation-market

The driving factors of the North American internal neuromodulation market are rising prevalence of neurological disorders, increase in the aging population, strong product pipeline, expanded target applications & new indications, and investments and funds. Unfavorable reimbursement scenario and lack of trained professionals are factors restraining the growth of the market. Technological advancements present opportunities for growth of the market.

Get sample of the Report: https://www.alliedmarketresearch.com/request-toc-and-sample/1035

The North American internal neuromodulation market is segmented into type, application, and geography. The market is further classified based on type into spinal cord, deep brain, sacral nerve, vagus nerve, gastric neuro stimulator. Based on applications, the market is further categorized into Parkinsons disease and chronic pain. The market is segmented based on geography into U.S., Canada, and Mexico.

KEY MARKET SEGMENTS:

By Type
- Spinal Cord Stimulator
- Deep Brain Stimulator
- Sacral Nerve Stimulator
- Vagus Nerve Stimulator
- Gastric Neuro Stimulator

By Application
- Parkinsons Disease
- Chronic Pain

By Country
- U.S.
- Canada
- Mexico

Key Market Player:

- Medtronic PLC
- St. Jude Medical
- Boston Scientific Corp.
- Cerbomed GMBH
- Cyberonics Inc.
- Biocontrol Medical
- Depuy Synthes Companies
- Enteromedics Inc.
- Synapse Biomedical INC.
- Uroplasty Inc.
- Greatbatch.